Trial Profile
An Open-Label, Single-Dose, Randomized, Four-Way Crossover Study In Healthy Volunteers To Evaluate The Effects Of A Low, Medium And High Fat Evening Meal On The Pharmacokinetics Of Pregabalin Controlled Release Formulation As Compared To The Immediate Release Formulation
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Jan 2021
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary) ; Pregabalin
- Indications Epilepsy; Neuropathic pain; Postherpetic neuralgia
- Focus Pharmacokinetics
- Sponsors Pfizer
- 03 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Apr 2011 Status changed from not yet recruiting to active, no longer recruitingas reported by ClinicalTrials.gov (NCT01270815).
- 04 Jan 2011 Planned end date changed from Mar 2011 to Apr 2011 as reported by ClinicalTrials.gov.